# Mirabegron and Urinary Urgency Incontinence

> **NCT02495389** · PHASE4 · COMPLETED · sponsor: **Loyola University** · enrollment: 84 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Mirabegron

## Key facts

- **NCT ID:** NCT02495389
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-28
- **Primary completion:** 2019-01-29
- **Final completion:** 2019-01-29
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2020-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02495389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02495389, "Mirabegron and Urinary Urgency Incontinence". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02495389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*